Seth A. Hyman
Founder and Chief Executive Officer
Seth Hyman has spent the last three decades as a serial entrepreneur building his own sales and marketing companies. His understanding and support of the campaign to legalize medical marijuana and hemp are rooted in his personal experiences.
Founder and President-Sales
Jeffrey Steiner’s knowledge of cutting-edge products and emerging marketing and sales channels in the hemp and CBD space brings depth and expertise to the Hempagenix™ team. A sales and marketing innovator who uses old and new school strategies to quickly build businesses from the ground up, he knows what drives conversions, and identifies valuable market opportunities for product lines as well as industry opportunities.
Scott Levin, MD
Vice President of Clinical Applications
Scott Levin, MD, joined Hempagenix™ in 2019 as vice president of clinical applications, intrigued by the idea of providing a hemp-based, over-the-counter solution for both acute and chronic pain. As the head of Hempagenix’s™ clinical division, he oversees a vast multitude of clinical applications for the company’s products, including Cannanumb™.
Gerald N. Robinson, MD, FACS
Director of Research & Development
A veteran of the U.S. Air Force, Gerald Robinson, MD, FACS, completed his training in general and vascular surgery at the Mayo Clinic in Rochester, MN, and entered private practice in general and vascular surgery in Boca Raton, FL.
Bruce S. Rosenwater, Esq.
Attorney Bruce S. Rosenwater is a veteran attorney, having assisted Floridians with legal issues for more than 20 years. Developing his law firm as a “law firm for life,” his practice areas span most, if not all, of an individual’s and a family’s lifetime legal needs.
Melissa J. Hyman
Corporate Brand Development
From a very early age, Melissa Hyman understood the importance of advocating for others. Her sister, Rebecca, who was the impetus for Hempagenix™, suffers from many medical issues and Melissa has always been by her side and has helped tremendously not only with her care but also in spreading awareness about epilepsy.